Exosomes as novel bio-carriers for gene and drug delivery

International Journal of Pharmaceutics

Volumn 521, Issue 1-2, 2017, Pages 167-175

  Jiang, Xin Chi ^a   Gao, Jian Qing ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Cell free therapies; Drug delivery system; Exosomes; Nucleic acids

Indexed keywords

NANOCARRIER; BIOLOGICAL PRODUCT; NANOPARTICLE;

CELL COMMUNICATION; CELL MEMBRANE; DRUG DELIVERY SYSTEM; ELECTROPORATION; ENDOSOME; EXOSOME; GENE TARGETING; PRIORITY JOURNAL; REVIEW; ULTRASOUND; ANIMAL; CHEMISTRY; GENE TRANSFER; HUMAN;

ANIMALS; BIOLOGICAL PRODUCTS; DRUG DELIVERY SYSTEMS; EXOSOMES; GENE TRANSFER TECHNIQUES; HUMANS; NANOPARTICLES;

EID: 85013841167     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2017.02.038     Document Type: Review

References (98)

1. Akao, Y., Iio, A., Itoh, T., Noguchi, S., Itoh, Y., Ohtsuki, Y., Naoe, T., Microvesicle-mediated RNA molecule delivery system using monocytes/macrophages. Mol. Ther. 19 (2011), 395–399.
2. Aled, C., Claire L, H., Jacquelyn, C., Mason, M.D., Paul, M.B., Antigen-presenting cell exosomes are protected from complement-mediated lysis by expression of CD55 and CD59. Eur. J. Immunol. 33 (2003), 522–531.
3. Alhasan, A.H., Patel, P.C., Choi, C.H., Mirkin, C.A., Exosome encased spherical nucleic acid gold nanoparticle conjugates as potent microRNA regulation agents. Small 10 (2014), 186–192.
4. Alvarez-Erviti, L., Seow, Y., Yin, H., Betts, C., Lakhal, S., Wood, M.J., Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat. Biotechnol. 29 (2011), 341–345.
5. Andaloussi, S.E., Lakhal, S., Mäger, I., Wood, M.J.A., Exosomes for targeted siRNA delivery across biological barriers ☆. Adv. Drug Deliver. Rev. 65 (2012), 391–397.
6. Andaloussi, S.E., Mäger, I., Breakefield, X.O., Wood, M.J.A., Extracellular vesicles: biology and emerging therapeutic opportunities. Nat. Rev. Drug Discov. 12 (2013), 347–357.
7. Anoek, Z., Carrie, M., Johannes, Frederik, Alwin, V., Ronny, K., Evelyne, S., Raymond Michel, B., Elzo, S., de, W., Jordi, B., Inge, Saskia, Johanna, E., In vivo imaging reveals extracellular vesicle-mediated phenocopying of metastatic behavior. Cell 161 (2015), 1046–1057.
8. Baulch, J.E., Acharya, M.M., Allen, B.D., Ru, N., Chmielewski, N.N., Martirosian, V., Giedzinski, E., Syage, A., Park, A.L., Benke, S.N., Parihar, V.K., Limoli, C.L., Cranial grafting of stem cell-derived microvesicles improves cognition and reduces neuropathology in the irradiated brain. Proc. Natl. Acad. Sci. U. S. A. 113 (2016), 4836–4841.
9. Bobrie, A., Colombo, M., Raposo, G., Théry, C., Exosome secretion: molecular mechanisms and roles in immune responses. Traffic 12 (2011), 1659–1668.
10. Braccioli, L., van Velthoven, C., Heijnen, C.J., Exosomes: a new weapon to treat the central nervous system. Mol. Neurobiol. 49 (2014), 113–119.
11. Bryniarski, K., Ptak, W., Jayakumar, A., Pullmann, K., Caplan, M.J., Chairoungdua, A., Lu, J., Adams, B.D., Sikora, E., Nazimek, K., Marquez, S., Kleinstein, S.H., Sangwung, P., Iwakiri, Y., Delgato, E., Redegeld, F., Blokhuis, B.R., Wojcikowski, J., Daniel, A.W., Groot Kormelink, T., Askenase, P.W., Antigen-specific, antibody-coated, exosome-like nanovesicles deliver suppressor T-cell microRNA-150 to effector T cells to inhibit contact sensitivity. J. Allergy Clin. Immunol. 132 (2013), 170–181.
12. Chen, L., Wang, Y., Pan, Y., Zhang, L., Shen, C., Qin, G., Ashraf, M., Weintraub, N., Ma, G., Tang, Y., Cardiac progenitor-derived exosomes protect ischemic myocardium from acute ischemia/reperfusion injury. Biochem. Biophys. Res. Commun. 431 (2013), 566–571.
13. Ciravolo, V., Huber, V., Ghedini, G.C., Venturelli, E., Bianchi, F., Campiglio, M., Morelli, D., Villa, A., Mina, P.D., Menard, S., Potential role of HER2-overexpressing exosomes in countering trastuzumab-based therapy. J. Cell. Physiol. 227 (2012), 658–667.
14. Clayton, A., Turkes, A., Dewitt, S., Steadman, R., Mason, M.D., Hallett, M.B., Adhesion and signaling by B cell-derived exosomes: the role of integrins. Faseb J. Off. Publ. Fed. Am. Soc. Exp. Biol. 18 (2004), 977–979.
15. Cvjetkovic, A., Lötvall, J., Lässer, C., The influence of rotor type and centrifugation time on the yield and purity of extracellular vesicles. J. Extracell Vesicles 3 (2014), 1–11.
16. Davis, M.E., Zhuo, C., Dong, M.S., Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat. Rev. Drug Discov. 7 (2008), 771–782.
17. Denzer, K., Kleijmeer, M.J., Heijnen, H.F., Stoorvogel, W., Geuze, H.J., Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. J. Cell Sci. 19:113 Pt (2000), 3365–3374.
18. Dinkins, M.B., Dasgupta, S., Wang, G., Zhu, G., Bieberich, E., Exosome reduction in vivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer's disease. Neurobiol. Aging 35 (2014), 1792–1800.
19. Du, F., Zhao, W.L., Ye, Y.Y., Bai, X.C., Liu, R.Q., Chang, L.F., Zhou, Q., Sui, S.F., Cellular internalization of exosomes occurs through phagocytosis. Traffic 11 (2010), 675–687.
20. El, A.S., Lakhal, S., Mäger, I., Wood, M.J., Exosomes for targeted siRNA delivery across biological barriers. Adv. Drug Deliver. Rev. 65 (2013), 391–397.
21. Elbashir, S.M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., Tuschl, T., Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411 (2015), 494–498.
22. Escudier, B., Dorval, T., Chaput, N., André, F., Caby, M.P., Novault, S., Flament, C., Leboulaire, C., Borg, C., Amigorena, S., Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial. J. Transl. Med. 3 (2005), 1–13.
23. Ferrari, M., Nanogeometry: beyond drug delivery. Nat. Nanotechnol. 3 (2008), 131–132.
24. Frühbeis, C., Fröhlich, D., Wen, P.K., Amphornrat, J., Thilemann, S., Saab, A.S., Kirchhoff, F., Möbius, W., Goebbels, S., Nave, K.A., Neurotransmitter-triggered transfer of exosomes mediates Oligodendrocyte–neuron communication. PLoS Biol., 11, 2013 e1001604-e1001604.
25. Frank-Kamenetsky, M., Fitzgerald, K., Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates. Proc. Natl. Acad. Sci. 105 (2008), 11915–11920.
26. Gajos-Michniewicz, A., Duechler, M., Czyz, M., MiRNA in melanoma-derived exosomes. Cancer Lett. 347 (2014), 29–37.
27. Gehl, J., Electroporation: theory and methods, perspectives for drug delivery, gene therapy and research. Acta Physiol. Scand. 177 (2003), 437–447.
28. Gong, M.Q., Wu, J.L., Chen, B., Zhuo, R.X., Cheng, S.X., Self-assembled polymer/inorganic hybrid nanovesicles for multiple drug delivery to overcome drug resistance in cancer chemotherapy. Langmuir Acs J. Surf. Colloids 31 (2015), 5115–5122.
29. Gould, S.J., Raposo, G., As we wait: coping with an imperfect nomenclature for extracellular vesicles. J. Extracell Vesicles, 2, 2013.
30. Gyorgy, B., Szabo, T.G., Pasztoi, M., Pal, Z., Misjak, P., Aradi, B., Laszlo, V., Pallinger, E., Pap, E., Kittel, A., Nagy, G., Falus, A., Buzas, E.I., Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell. Mol. Life Sci. 68 (2011), 2667–2688.
31. Haney, M.J., Klyachko, N.L., Zhao, Y., Gupta, R., Plotnikova, E.G., He, Z., Patel, T., Piroyan, A., Sokolsky, M., Kabanov, A.V., Exosomes as drug delivery vehicles for Parkinson's disease therapy. J. Controlled Release 207 (2015), 18–30.
32. Hannafon, B.N., Ding, W.Q., Intercellular communication by exosome-derived microRNAs in cancer. Int. J. Mol. Sci. 14 (2013), 14240–14269.
33. Hong, B.S., Cho, J.H., Kim, H., Choi, E.J., Rho, S., Kim, J., Ji, H.K., Choi, D.S., Kim, Y.K., Hwang, D., Colorectal cancer cell-derived microvesicles are enriched in cell cycle-related mRNAs that promote proliferation of endothelial cells. Bmc Genomics 10 (2009), 4212–4224.
34. Hood, J.L., Scott, M.J., Wickline, S.A., Maximizing exosome colloidal stability following electroporation. Anal. Biochem. 448 (2014), 41–49.
35. Hu, Y.L., Fu, Y.H., Tabata, Y., Gao, J.Q., Mesenchymal stem cells: a promising targeted-delivery vehicle in cancer gene therapy. J. Controlled Release 147 (2010), 154–162.
36. Hu, Y.L., Huang, B., Zhang, T.Y., Miao, P.H., Tang, G.P., Tabata, Y., Gao, J.Q., Mesenchymal stem cells as a novel carrier for targeted delivery of gene in cancer therapy based on nonviral transfection. Mol. Pharm. 9 (2012), 2698–2709.
37. Hu, Y.L., Miao, P.H., Huang, B., Zhang, T.Y., Hu, Z.J., Tabata, Y., Gao, J.Q., Reversal of tumor growth by gene modification of mesenchymal stem cells using spermine-pullulan/DNA nanoparticles. J. Biomed. Nanotechnol. 10 (2013), 299–308.
38. Johnsen, K.B., Gudbergsson, J.M., Skov, M.N., Pilgaard, L., Moos, T., Duroux, M., A comprehensive overview of exosomes as drug delivery vehicles – endogenous nanocarriers for targeted cancer therapy. Biochim. Biophys. Acta 1846 (2014), 75–87.
39. Johnstone, R.M., Adam, M., Hammond, J.R., Orr, L., Turbide, C., Vesicle formation during reticulocyte maturation: association of plasma membrane activities with released vesicles (exosomes). J. Biol. Chem. 262 (1987), 9412–9420.
40. Kahlert, C., Kalluri, R., Exosomes in tumor microenvironment influence cancer progression and metastasis. J. Mol. Med. 91 (2013), 431–437.
41. Kalani, A., Kamat, P.K., Chaturvedi, P., Tyagi, S.C., Tyagi, N., Curcumin-primed exosomes mitigate endothelial cell dysfunction during hyperhomocysteinemia. Life Sci. 107 (2014), 1–7.
42. Kalani, A., Tyagi, A., Tyagi, N., Exosomes: mediators of neurodegeneration, neuroprotection and therapeutics. Mol. Neurobiol. 49 (2014), 590–600.
43. Kalra, H., Adda, C.G., Liem, M., Ang, C.S., Mechler, A., Simpson, R.J., Hulett, M.D., Mathivanan, S., Comparative proteomics evaluation of plasma exosome isolation techniques and assessment of the stability of exosomes in normal human blood plasma. Proteomics 13 (2013), 3354–3364.
44. Kim, W.J., Kim, S.W., Efficient siRNA delivery with non-viral polymeric vehicles. Pharmaceut. Res. 26 (2009), 657–666.
45. Kim, D.K., Kang, B., Kim, O.Y., Choi, D.S., Lee, J., Kim, S.R., Go, G., Yoon, Y.J., Kim, J.H., Jang, S.C., EVpedia: an integrated database of high-throughput data for systemic analyses of extracellular vesicles. J. Extracellular Vesicles 2 (2013), 20384–20390.
46. Kim, M.S., Haney, M.J., Zhao, Y., Mahajan, V., Deygen, I., Klyachko, N.L., Inskoe, E., Piroyan, A., Sokolsky, M., Okolie, O., Hingtgen, S.D., Kabanov, A.V., Batrakova, E.V., Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells. Nanomed. Nanotechnol. Biol. Med. 12 (2016), 655–664.
47. Kooijmans, S.A., Vader, P., van Dommelen, S.M., van Solinge, W.W., Schiffelers, R.M., Exosome mimetics: a novel class of drug delivery systems. Int. J. Nanomed. 7 (2012), 1525–1541.
48. Kowalczuk, A., Stoyanova, E., Mitova, V., Shestakova, P., Momekov, G., Momekova, D., Koseva, N., Star-shaped nano-conjugates of cisplatin with high drug payload. Int. J. Pharm., 404, 2011, 220.
49. Lai, C.P., Kim, E.Y., Badr, C.E., Weissleder, R., Mempel, T.R., Tannous, B.A., Breakefield, X.O., Visualization and tracking of tumour extracellular vesicle delivery and RNA translation using multiplexed reporters. Nat. Commun., 6, 2015, 7029.
50. Lakhal, S., Wood, M.J.A., Exosome nanotechnology: an emerging paradigm shift in drug delivery. Bioessays 33 (2011), 737–741.
51. Lasser, C., Eldh, M., Lotvall, J., Isolation and characterization of RNA-containing exosomes. J. Vis Exp., 2012, e3037.
52. Li, X.M., Ding, L.Y., Xu, Y., Wang, Y., Ping, Q.N., Targeted delivery of doxorubicin using stealth liposomes modified with transferrin. Int. J. Pharm. 373 (2009), 116–123.
53. Liu, R., Liu, J., Ji, X., Liu, Y., Synthetic nucleic acids delivered by exosomes: a potential therapeutic for generelated metabolic brain diseases. Metab. Brain Dis. 28 (2013), 551–562.
54. Lobb, R.J., Becker, M., Wen, S.W., Wong, C.S., Wiegmans, A.P., Leimgruber, A., Moller, A., Optimized exosome isolation protocol for cell culture supernatant and human plasma. J. Extracell Vesicles, 4, 2015, 27031.
55. Melo, S.A., Luecke, L.B., Kahlert, C., Fernandez, A.F., Gammon, S.T., Kaye, J., Lebleu, V.S., Mittendorf, E.A., Weitz, J., Rahbari, N., Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature, 523, 2015, 177.
56. Montecalvo, A., Larregina, A.T., Shufesky, W.J., Stolz, D.B., Sullivan, M.L., Karlsson, J.M., Baty, C.J., Gibson, G.A., Erdos, G., Wang, Z., Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes. Blood 119 (2012), 756–766.
57. Moritake, S., Taira, S., Ichiyanagi, Y., Morone, N., Song, S.Y., Hatanaka, T., Yuasa, S., Setou, M., Functionalized nano-magnetic particles for an in vivo delivery system. J. Nanosci. Nanotechnol. 7 (2007), 937–944.
58. Morse, M.A., Garst, J., Osada, T., Khan, S., Hobeika, A., Clay, T.M., Valente, N., Shreeniwas, R., Sutton, M.A., Delcayre, A., A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer. J. Transl. Med., 3, 2005 659-659.
59. Ohno, S., Takanashi, M., Sudo, K., Ueda, S., Ishikawa, A., Matsuyama, N., Fujita, K., Mizutani, T., Ohgi, T., Ochiya, T., Gotoh, N., Kuroda, M., Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells. Mol. Ther. 21 (2013), 185–191.
60. Pan, B.T., Johnstone, R.M., Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: selective externalization of the receptor. Cell 33 (1983), 967–978.
61. Pascucci, L., Cocce, V., Bonomi, A., Ami, D., Ceccarelli, P., Ciusani, E., Vigano, L., Locatelli, A., Sisto, F., Doglia, S.M., Parati, E., Bernardo, M.E., Muraca, M., Alessandri, G., Bondiolotti, G., Pessina, A., Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery. J. Controlled Release Off. J. Controlled Release Soc. 192 (2014), 262–270.
62. Pegtel, D.M., Kieff, E., Functional delivery of viral miRNAs via exosomes. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 6328–6333.
63. Peinado, H., Alečković, M., Lavotshkin, S., Matei, I., Costa-Silva, B., Moreno-Bueno, G., Hergueta-Redondo, M., Williams, C., García-Santos, G., Nitadori-Hoshino, A., Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat. Med. 18 (2012), 883–891.
64. Prete, A.C.L., Maria, D.A., Rodrigues, D.B.G., Valduga, C.J., Ibañez, O.C.M., Maranhão, R.C., Evaluation in melanoma-bearing mice of an etoposide derivative associated to a cholesterol-rich nanoemulsion. J. Pharm. Pharmacol. 58 (2006), 801–808.
65. Qin, J., Xu, Q., Functions and application of exosomes. Acta Pol. Pharm. 71 (2014), 537–543.
66. Rao, Q., Zuo, B., Lu, Z., Gao, X., You, A., Wu, C., Du, Z., Yin, H., Tumor-derived exosomes elicit tumor suppression in murine hepatocellular carcinoma models and humans in vitro. Hepatology, 64, 2016, 456.
67. Record, M., Subra, C., Silvente-Poirot, S., Poirot, M., Exosomes as intercellular signalosomes and pharmacological effectors. Biochem. Pharmacol. 81 (2011), 1171–1182.
68. Redman, C.W., Tannetta, D.S., Dragovic, R.A., Gardiner, C., Southcombe, J.H., Collett, G.P., Sargent, I.L., Review: does size matter? Placental debris and the pathophysiology of pre-eclampsia. Placenta 33:Suppl (2012), S48–54.
69. Ridder, K., Sevko, A., Heide, J., Dams, M., Rupp, A.K., Macas, J., Starmann, J., Tjwa, M., Plate, K.H., Sültmann, H., Extracellular vesicle-mediated transfer of functional RNA in the tumor microenvironment. Oncoimmunology 4 (2015), e1008371–e1008378.
70. Rosi, N.L., Giljohann, D.A., Thaxton, C.S., Lytton-Jean, A.K.R., Han, M.S., Mirkin, C.A., Oligonucleotide-modified gold nanoparticles for intracellular gene regulation. Science 312 (2006), 1027–1030.
71. Ruan, G.X., Chen, Y.Z., Yao, X.L., Du, A., Tang, G.P., Shen, Y.Q., Tabata, Y., Gao, J.Q., Macrophage mannose receptor-specific gene delivery vehicle for macrophage engineering. Acta Biomater., 10, 2014, 1847.
72. Ruiss, R., Jochum, S., Mocikat, R., Hammerschmidt, W., Zeidler, R., EBV-gp350 Confers B-Cell Tropism to Tailored Exosomes and Is a Neo-Antigen in Normal and Malignant B Cells—A New Option for the Treatment of B-CLL, 6, 2011, e25294.
73. Sharma, S., Rasool, H.I., Palanisamy, V., Mathisen, C., Schmidt, M., Wong, D.T., Gimzewski, J.K., Structural-mechanical characterization of nanoparticle exosomes in human saliva, using correlative AFM, FESEM, and force spectroscopy. ACS Nano 4 (2010), 1921–1926.
74. Shtam, T.A., Kovalev, R.A., Varfolomeeva, E.Y., Makarov, E.M., Kil, Y.V., Filatov, M.V., Exosomes are natural carriers of exogenous siRNA to human cells in vitro. Cell Commun. Signaling Ccs 11 (2013), 1–10.
75. Shubayev, V.I., Nd, P.T., Jin, S., Magnetic nanoparticles for theragnostics. Adv. Drug Deliver. Rev. 61 (2009), 467–477.
76. Simpson, R.J., Jensen, S.S., Lim, J.W.E., Proteomic profiling of exosomes: current perspectives. Proteomics 8 (2008), 4083–4099.
77. Sims, P.J., Faioni, E.M., Wiedmer, T., Shattil, S.J., Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. J. Biol. Chem. 263 (1988), 18205–18212.
78. Smith, J.A., Leonardi, T., Huang, B., Iraci, N., Vega, B., Pluchino, S., Extracellular vesicles and their synthetic analogues in aging and age-associated brain diseases. Biogerontology 16 (2015), 147–185.
79. Su, C.J., Kim, O.Y., Chang, M.Y., Choi, D.S., Roh, T.Y., Park, J., Nilsson, J., Lötvall, J., Kim, Y.K., Yong, S.G., Bioinspired exosome-Mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors. ACS Nano 7 (2013), 7698–7710.
80. Sun, D., Zhuang, X.X., Liu, Y., Zhang, S., Liu, C., Barnes, S., Grizzle, W., Miller, D., Zhang, H.G., A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. Mol. Ther. J. Am. Soc. Gene Ther. 18 (2010), 1606–1614.
81. Tauro, B.J., Greening, D.W., Mathias, R.A., Ji, H., Mathivanan, S., Scott, A.M., Simpson, R.J., Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863 exosomes. Methods 56 (2012), 293–304.
82. Théry, C., Ostrowski, M., Segura, E., Membrane vesicles as conveyors of immune responses. Nat. Rev. Immunol. 9 (2009), 581–593.
83. Tian, Y., Li, S., Song, J., Ji, T., Zhu, M., Anderson, G.J., Wei, J., Nie, G., A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. Biomaterials 35 (2014), 2383–2390.
84. Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J.J., Lötvall, J.O., Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell. Biol. 9 (2007), 654–659.
85. Vallhov, H., Gutzeit, C., Johansson, S.M., Nagy, N., Paul, M., Li, Q., Friend, S., George, T.C., Klein, E., Scheynius, A., Gabrielsson, S., Exosomes containing glycoprotein 350 released by EBV-transformed B cells selectively target B cells through CD21 and block EBV infection in vitro. J. Immunol. 186 (2011), 73–82.
86. Vlassov, A.V., Magdaleno, S., Setterquist, R., Conrad, R., Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochim. Biophys. Acta 1820 (2012), 940–948.
87. Wahlgren, J., Karlson, T.D.L., Brisslert, M., Sani, F.V., Telemo, E., Sunnerhagen, P., Valadi, H., Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes. Nucleic Acids Res. 40 (2012), 610–621.
88. Xin, H., Li, Y., Cui, Y., Yang, J.J., Zhang, Z.G., Chopp, M., Systemic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats. J. Cereb. Blood Flow Metab.: Off. J. Int. Soc. Cereb. Blood Flow Metab. 33 (2013), 1711–1715.
89. Yousefpour, P., Chilkoti, A., Co-opting biology to deliver drugs. Biotechnol. Bioeng. 111 (2014), 1699–1716.
90. Zhang, Z.G., Chopp, M., Exosomes in stroke pathogenesis and therapy. J. Clin. Invest. 126 (2016), 1190–1197.
91. Zhang, T.Y., Huang, B., Yuan, Z.Y., Hu, Y.L., Tabata, Y., Gao, J.Q., Gene recombinant bone marrow mesenchymal stem cells as a tumor-targeted suicide gene delivery vehicle in pulmonary metastasis therapy using non-viral transfection. Nanomed. Nanotechnol. Biol. Med. 10 (2014), 257–267.
92. Zhang, T.Y., Huang, B., Wu, H.B., Wu, J.H., Li, L.M., Li, Y.X., Hu, Y.L., Han, M., Shen, Y.Q., Tabata, Y., Synergistic effects of co-administration of suicide gene expressing mesenchymal stem cells and prodrug-encapsulated liposome on aggressive lung melanoma metastases in mice. J. Controlled Release Off. J. Controlled Release Soc. 209 (2015), 260–271.
93. Zhang, Y., Chopp, M., Meng, Y., Katakowski, M., Xin, H., Mahmood, A., Xiong, Y., Effect of exosomes derived from multipluripotent mesenchymal stromal cells on functional recovery and neurovascular plasticity in rats after traumatic brain injury. J. Neurosurg. 122 (2015), 856–867.
94. Zhu, X., He, Z., Yuan, J., Wen, W., Huang, X., Hu, Y., Lin, C., Pan, J., Li, R., Deng, H., Liao, S., Zhou, R., Wu, J., Li, J., Li, M., IFITM3-containing exosome as a novel mediator for anti-viral response in dengue virus infection. Cell. Microbiol. 17 (2015), 105–118.
95. Zhuang, X., Xiang, X., Grizzle, W., Sun, D., Zhang, S., Axtell, R.C., Ju, S., Mu, J., Zhang, L., Steinman, L., Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. Mol. Ther. J. Am. Soc. Gene Ther. 19 (2011), 1769–1779.
96. de Boer, A.G., Gaillard, P.J., Strategies to improve drug delivery across the blood-brain barrier. Clin. Pharmacokinet. 46 (2007), 553–576.
97. van Dommelen, S.M., Vader, P., Lakhal, S., Kooijmans, S.A., van Solinge, W.W., Wood, M.J., Schiffelers, R.M., Microvesicles and exosomes: opportunities for cell-derived membrane vesicles in drug delivery. J. Controlled Release: Off. J. Controlled Release Soc. 161 (2012), 635–644.
98. van Niel, G., Porto-Carreiro, I., Simoes, S., Raposo, G., Exosomes: a common pathway for a specialized function. J. Biochem. 140 (2006), 13–21.